Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

66.12
+1.051.61%
Pre-market: 66.270.1500+0.23%09:08 EDT
Volume:1.36M
Turnover:89.66M
Market Cap:12.78B
PE:174.47
High:66.36
Open:65.03
Low:65.02
Close:65.07
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:0.75
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:2.02
PE(LYR):36.73

Loading ...

Nov 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 28, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 26, 2023

Major Issues Report

8-K - Current report
Apr 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 06, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 06, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities